Congresswoman Maggie Goodlander and colleagues urge CMS to halt the proposed expansion of prior authorization in Traditional Medicare, citing risks to patient care and administrative burdens.

CMS plans a voluntary five-year trial allowing state Medicaid and Medicare Part D plans to cover GLP-1 weight management drugs, including Ozempic and Wegovy, starting in 2026-27 amid pricing and coverage challenges.

Medicare faces evolving opportunities and challenges in covering weight loss drugs through legislation like the Treat and Reduce Obesity Act and federal demonstration projects. Drug adherence and cost-effectiveness remain key issues.

Illinois Secretary of State launches 'Driving Change' campaign targeting socioeconomic biases in auto insurance rates. Legislation seeks to enhance transparency and rate review.

The Department of Labor proposes rescinding a regulatory safe harbor for annuity selection in retirement plans, raising fiduciary concerns and market impact ahead of SECURE 2.0 implementation.

Colorado residents may see health insurance premiums rise up to 196% as expiring tax credits end, impacting affordability and increasing out-of-pocket costs. Regulatory reviews underway.

Conning analysts forecast sustained growth in life/annuity and property/casualty insurance in 2025, driven by economic conditions, regulatory focus, AI adoption, and rising catastrophe and cyber risks.

The 'One Big Beautiful Bill Act' introduces sweeping changes to US health and P&C insurance, including Medicaid cuts, ACA subsidy restrictions, and new tax incentives, reshaping market dynamics through 2034.

UnitedHealth Group's stock has fallen 50% amid sector-wide challenges and regulatory scrutiny. The upcoming earnings report and guidance will be pivotal for investor confidence.

UnitedHealth Group confirms DOJ investigations into Medicare billing and diagnosis code practices, impacting regulatory compliance and Medicare program integrity.